Who is sponsoring NCT01541241?

NCT01541241 is sponsored by Egymedicalpedia.

What condition does NCT01541241 study?

NCT01541241 studies Copper Intrauterine Device Induced Bleeding.

Is NCT01541241 still recruiting?

NCT01541241 is currently completed. Last updated 4 December 2020.

Last reviewed 2020-12-04 · How we verify

NCT01541241: IUD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study About Patients Using Copper Intrauterine Device

Completed Last updated 4 December 2020

What this trial tests

trial in Copper Intrauterine Device Induced Bleeding in 100 participants. Completed in 30 May 2012.

Timeline

2 January 2012

Primary endpoint
28 February 2012

30 May 2012

Quick facts

Lead sponsor	Egymedicalpedia
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	2 January 2012
Primary completion	28 February 2012
Estimated completion	30 May 2012
Sites	1 location across Egypt

Conditions studied

Copper Intrauterine Device Induced Bleeding — all drugs for Copper Intrauterine Device Induced Bleeding →

Sponsor

Egymedicalpedia — full company profile →

Who can join

Adults 18 to 35, female only, with Copper Intrauterine Device Induced Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

THE AIM OF THE this study is to assess the hemodynamic changes of uterine artery in patients with CIUD induced bleeding by using transvaginal color Doppler indices (uterine artery resistance index and pulsatility index) to prove the relationship between these changes and bleeding in these patient .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Egymedicalpedia trials

Trials by the same sponsor.

NCT06590818 — The Effect of Body Mass Index on Short-term Results of HTO · NA · recruiting
NCT06583811 — Remifentanil and Remimazolam to Limit Patient Movement · NA · recruiting
NCT06522984 — Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid · NA · recruiting
NCT06370078 — Effect of Early Administration of Albumin 20% Versus Crystalloid · NA · recruiting
NCT06370221 — The Effect of Psoriatic Arthritis on Female Sexual Dysfunction · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01541241 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Egymedicalpedia
Last refreshed: 4 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01541241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing